H · O · Cl · Hypochlorous Acid
HyPuros is a Rapid-Cycle Operational Disinfection System engineered for regulated, high-throughput environments where speed and documentation are both non-negotiable.
HyPuros does not compete in the "disinfectant" commodity category.
It occupies a new one: Rapid-Cycle Operational Disinfection System.
"Clinical turnaround without shortcuts."
Rapid-cycle HOCl disinfection for hospitals and clinical environments. Auditable protocol, documentation ready for JCI, TJC, and accreditation review — at every application. Designed to reduce bed and room turnaround time without changing your infection control protocol.
"Sanitation that keeps the line running."
HACCP-compatible documentation at every cycle. SOP integration with existing line protocols. Engineered to shorten the sanitation window without compromising food-contact surface safety — turning sanitation downtime into production uptime.
"System microbial control. Without unnecessary chemistry."
Precise dosing for closed industrial water systems. HOCl's documented decomposition profile — breaking down to water and trace chlorides — is operationally and environmentally advantageous versus traditional chlorine-based chemistries.
HOCl is a naturally occurring antimicrobial compound — the same molecule produced by the human immune system. At the correct pH and concentration, it delivers broad-spectrum microbial control with evidence, audit trail, and documentation built in.
Designed to reduce cycle time in high-throughput clinical rooms, food production lines, and water treatment systems — with every application logged and documentable.
SOP + application log + accreditation-ready report. HyPuros is not a supply item — it is infrastructure. Switching means gaining documentation your quality team has always needed.
The CONC format contributes to measurable reductions in logistics, storage, and per-cycle cost. Packaging reduction, freight frequency, and effluent data — all quantifiable for ESG reporting.
3–5 structured pilot sites. KPIs defined in writing before Day 1. SOP, application log, and staff training delivered at each site.
Pilot data converted into sector-specific sales tools. Anonymised case studies with before/after KPIs and full ROI model.
Second case study published. Performance Pilot offer launched. First contract conversions at minimum two sites.
HyPuros becomes the brand that defines the Rapid-Cycle Operational Disinfection System category — not merely a participant.
The greatest barrier to adoption in regulated sectors is not price — it is the risk of change. HyPuros validation programmes are designed to eliminate that risk by generating client-owned evidence inside the client's own environment.
Structured pilot with KPIs defined before Day 1. Includes customised SOP, staff training, application log, and final technical report. For prospects who need internal evidence to justify approval.
Internal implementation certification confirming the protocol is correctly configured and validated. Signed SOP, validated application log, audit checklist, and verification report.
30/60/90-day structured pilot with ROI model completed with real client data. For operations and procurement managers who need to justify investment quantitatively.
Assisted implementation for the first 90 days post-contract. Team training, integrated SOP, KPI reviews at 30/60/90 days, and remote technical support included.
Same regulatory outcome. Dramatically different operational reality.
Tell us about your facility and sector. We'll design the pilot — KPIs agreed before Day 1, documented report at the end.
Hospitals · Food Manufacturing · Water Treatment · Brazil → USA
HyPuros is developed and owned by
The world's only commercial-scale producer of stable, high-purity HOCl — engineered for infection control across healthcare, water treatment, and agriculture. NHS-registered. Based in the UK.
Visit website
Commercialization strategy and executive recruitment for life sciences — from product development through global market launch. Licensing, distribution partnerships, and go-to-market execution across Europe, Americas, and Asia Pacific.
Visit websiteHyPuros is a brand developed and owned by Supra Perfecta and CollaBio — two healthcare innovation companies united by a commitment to advancing disinfection standards globally.